|
1
|
Ryu ES, Kim MJ, Shin HS, Jang YH, Choi HS,
Jo I, Johnson RJ and Kang DH: Uric acid-induced phenotypic
transition of renal tubular cells as a novel mechanism of chronic
kidney disease. Am J Physiol Renal Physiol.
304(F471-F480)2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Siu YP, Leung KT, Tong MK and Kwan TH: Use
of allopurinol in slowing the progression of renal disease through
its ability to lower serum uric acid level. Am J Kidney Dis.
47:51–59. 2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ghaemi-Oskouie F and Shi Y: The role of
uric acid as an endogenous danger signal in immunity and
inflammation. Curr Rheumatol Rep. 13:160–166. 2011.[J]. PubMed/NCBI View Article : Google Scholar
|
|
4
|
Roddy E, Zhang W and Doherty M: The
changing epidemiology of gout. Nat Clin Pract Rheumatol. 3:443–449.
2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kim IY, Lee DW, Lee SB and Kwak IS: The
role of uric acid in kidney fibrosis: Experimental evidences for
the causal relationship. BioMed Res Int. 2014(638732)2014.
View Article : Google Scholar
|
|
6
|
Saito I, Saruta T, Kondo K, Nakamura R,
Oguro T, Yamagami K, Ozawa Y and Kato E: Serum uric acid and the
renin-angiotensin system in hypertension. J Am Geriatr Soc.
26:241–247. 1978.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gao L, Shen F and Lii YS: Effects of
NLRP3 inflammasome on cerebral ischemia reperfusion
injury. J Shanghai Jiaotong University Medical Science.
35:1896–1899. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Heneka MT, Kummer MP, Stutz A, Delekate A,
Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, et
al: NLRP3 is activated in Alzheimer's disease and
contributes to pathology in APP/PS1 mice. Nature. 493:674–678.
2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tschopp J and Schroder K: NLRP3
inflammasome activation: The convergence of multiple signalling
pathways on ROS production? Nat Rev Immunol. 10:210–215.
2010.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Zheng SC, Zhu XX, Xue Y, Zhang LH, Zou HJ,
Qiu JH and Liu Q: Role of the NLRP3 inflammasome in the
transient release of IL-1β induced by monosodium urate crystals in
human fibroblast-like synoviocytes. J Inflamm (Lond).
12(30)2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Schiltz C, Lioté F, Prudhommeaux F,
Meunier A, Champy R, Callebert J and Bardin T: Monosodium urate
monohydrate crystal-induced inflammation in vivo: Quantitative
histomorphometric analysis of cellular events. Arthritis Rheum.
46:1643–1650. 2002.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Xu X, Hu J, Song N, Chen R, Zhang T and
Ding X: Hyperuricemia increases the risk of acute kidney injury: A
systematic review and meta-analysis. BMC Nephrol. 18:27–41.
2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wallace SL, Robinson H, Masi AT, Decker
JL, McCarty DJ and Yü TF: Preliminary criteria for the
classification of the acute arthritis of primary gout. Arthritis
Rheum. 20:895–900. 1977.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang XX, Sun WF, Hou Y, Liu YW and He Y:
Clinical observation on fufang tufuling keli treating 40 cases of
hyperuricemia: a randomize-controlled study. J Tradit Chin Med.
57:41–45. 2016.
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-ΔΔC(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Levey AS, de Jong PE, Coresh J, El Nahas
M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL and Eckardt
KU: The definition, classification, and prognosis of chronic kidney
disease: A KDIGO Controversies Conference report. Kidney Int.
80:17–28. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Weiner DE, Tighiouart H, Elsayed EF,
Griffith JL, Salem DN and Levey AS: Uric Acid and incident kidney
disease in thy community. J Am soc Nephriol. 19:1204–1211.
2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Weiner DE, Tighiouart H, Elsayed EF,
Griffith JL, Salem DN and Levey AS: Uric acid and incident kidney
disease in the community. J Am Soc Nephrol. 19:1204–1211.
2008.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sánchez-Lozada LG, Soto V, Tapia E,
Avila-Casado C, Sautin YY, Nakagawa T, Franco M, Rodríguez-Iturbe B
and Johnson RJ: Role of oxidative stress in the renal abnormalities
induced by experimental hyperuricemia. Am J Physiol Renal Physiol.
295(F1134-F1141)2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kang DH, Nakagawa T, Feng L, Watanabe S,
Han L, Mazzali M, Truong L, Harris R and Johnson RJ: A role for
uric acid in the progression of renal disease. J Am Soc Nephrol.
13:2888–2897. 2002.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Liu LQ: Pathogenesis of hyperuric acid
nephropathy. J Clin Nephrol. 11:53–55. 2011.
|
|
22
|
Kanellis J, Watanabe S, Li JH, Kang DH, Li
P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, et al:
Uric acid stimulates monocyte chemoattractant protein-1 production
in vascular smooth muscle cells via mitogen-activated protein
kinase and cyclooxygenase-2. Hypertension. 41:1287–1293. 2003.[J].
PubMed/NCBI View Article : Google Scholar
|
|
23
|
Prasad Sah OS and Qing YX: Associations
between hyperuricemia and chronic kidney disease: A Review.
Nephrourol Mon. 7(e27233)2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gul A and Zager P: Does altered uric acid
metabolism contribute to diabetic kidney disease pathophysiology?
Curr Diab Rep. 18(18)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Braga TT, Forni MF, Correa-Costa M, Ramos
RN, Barbuto JA, Branco P, Castoldi A, Hiyane MI, Davanso MR, Latz
E, et al: Soluble uric acid activates the NLRP3
inflammasome. Sci Rep. 7(39884)2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Isaka Y, Takabatake Y, Takahashi A, Saitoh
T and Yoshimori T: Hyperuricemia-induced inflammasome and kidney
diseases. Nephrol Dial Transplant. 31:890–896. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Baroja-Mazo A, Martín-Sánchez F, Gomez AI,
Martínez CM, Amores-Iniesta J, Compan V, Barberà-Cremades M, Yagüe
J, Ruiz-Ortiz E, Antón J, et al: The NLRP3 inflammasome
is released as a particulate danger signal that amplifies the
inflammatory response. Nat Immunol. 15:738–748. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Xia M, Boini KM, Abais JM, Xu M, Zhang Y
and Li PL: Endothelial NLRP3 inflammasome activation and
enhanced neointima formation in mice by adipokine visfatin. Am J
Pathol. 184:1617–1628. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhou R, Tardivel A, Thorens B, Choi I and
Tschopp J: Thioredoxin-interacting protein links oxidative stress
to inflammasome activation. Nat Immunol. 11:136–140.
2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Martinon F: Signaling by ROS drives
inflammasome activation. Eur J Immunol. 40:616–619. 2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Gasse P, Riteau N, Charron S, Girre S,
Fick L, Pétrilli V, Tschopp J, Lagente V, Quesniaux VF, Ryffel B,
et al: Uric acid is a danger signal activating NALP3 inflammasome
in lung injury inflammation and fibrosis. Am J Respir Crit Care
Med. 179:903–913. 2009.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Jiang H, Yan YQ, Jiang W and Zhou RB:
NLRP3 inflammasome: Activation, regulation, and role in
diseases. Sci Sin Vitae. 47:125–131. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhou R, Yazdi AS, Menu P and Tschopp J: A
role for mitochondria in NLRP3 inflammasome activation.
Nature. 469:221–225. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Jin-Feng LI, Xie D, Ping-Ping HE, Tang YY,
Yu-Lin TU and Yin K: Research advances of the NLRP3
inflammasome and metabolic disease. Prog Biochem Biophys.
41:425–434. 2014. View Article : Google Scholar
|
|
35
|
Martinon F, Pétrilli V, Mayor A, Tardivel
A and Tschopp J: Gout-associated uric acid crystals activate the
NALP3 inflammasome. Nature. 440:237–241. 2006.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Xu LL: NLRP3 inflammasomes and
kidney diseases. J Nephrol Dialy Transpl. 20:554–558.
2011.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Hornung V, Bauernfeind F, Halle A, Samstad
EO, Kono H, Rock KL, Fitzgerald KA and Latz E: Silica crystals and
aluminum salts activate the NALP3 inflammasome through phagosomal
destabilization. Nat Immunol. 9:847–856. 2008.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Stutz A, Golenbock DT and Latz E:
Inflammasomes: Too big to miss. J Clin Invest. 119:3502–3511.
2009.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kim SM, Lee SH, Kim YG, Kim S-Y, Seo JW,
Choi YW, Kim DJ, Jeong KH, Lee TW, Ihm CG, et al:
Hyperuricemia-induced NLRP3 activation of macrophage
contributes to the progression of diabetic nephropathy. Am J
Physiol-renal. 308:993–1003. 2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Liu YF, Wen CY, Chen Z, Wang Y, Huang Y
and Tu SH: Effects of berberine on NLRP3 and IL-1β
expressions in monocytic THP-1 cells with monosodium urate
crystals-induced inflammation. Biomed Res Int. 2016(2503703)2016.
View Article : Google Scholar
|
